Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALGANCICLOVIR Cause Activated partial thromboplastin time prolonged? 33 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Activated partial thromboplastin time prolonged have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.4% of all adverse event reports for VALGANCICLOVIR.

33
Reports of Activated partial thromboplastin time prolonged with VALGANCICLOVIR
0.4%
of all VALGANCICLOVIR reports
0
Deaths
33
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From VALGANCICLOVIR?

Of the 33 reports, 33 (100.0%) required hospitalization.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does VALGANCICLOVIR Cause?

Off label use (1,882) Cytomegalovirus infection (1,091) Drug ineffective (886) Neutropenia (809) Leukopenia (574) Drug resistance (524)